Dopamine < Dopamine Agents < Dopamine Agonists

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 137.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000081 (1999)	E. Grünblatt [Israël] ; S. Mandel ; T. Berkuzki ; M B Youdim	Apomorphine protects against MPTP-induced neurotoxicity in mice.
000217 (2000)	C W Olanow [États-Unis] ; A H Schapira ; T. Roth	Waking up to sleep episodes in Parkinson's disease.
000235 (2000)	V G Evidente [États-Unis] ; C H Adler ; J N Caviness ; J G Hentz ; K. Gwinn-Hardy	Amantadine is beneficial in restless legs syndrome.
000297 (2000)	J. Kulisevsky [Espagne] ; C. García-Sánchez ; M L Berthier ; M. Barbanoj ; B. Pascual-Sedano ; A. Gironell ; A. Estévez-González	Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients.
000314 (2000)	E. Růzicka [République tchèque] ; J. Roth ; R. Jech ; P. Busek	Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease.
000329 (2000)	S A Treseder [Royaume-Uni] ; L A Smith ; P. Jenner	Endogenous dopaminergic tone and dopamine agonist action.
000364 (2000)	H A Hana Asi [Turquie] ; G. Kaptanoglu ; H A Sahin ; M. Emre	The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa.
000390 (2000)	K J Black [États-Unis] ; J W Mink	Response to levodopa challenge in Tourette syndrome.
000458 (2001)	H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C Hirsch	Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000461 (2001)	G M Petzinger [États-Unis] ; M. Quik ; E. Ivashina ; M W Jakowec ; M. Jakubiak ; D. Di Monte ; J W Langston	Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate.
000499 (2001)	K P Datla [Royaume-Uni] ; S B Blunt ; D T Dexter	Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
000512 (2001)	P. Del Dotto [Italie] ; N. Pavese ; G. Gambaccini ; S. Bernardini ; L V Metman ; T N Chase ; U. Bonuccelli	Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study.
000634 (2001)	B. Högl ; K. Seppi ; E. Brandauer ; G. Wenning ; Werner Poewe [Autriche]	Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): placebo-controlled, polysomnographic case report.
000647 (2002)	Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta Imperato	Neuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000790 (2002)	Oleh Hornykiewicz [Autriche]	Dopamine miracle: from brain homogenate to dopamine replacement.
000886 (2002)	Ronald K B. Pearce [Royaume-Uni] ; Lance A. Smith ; Michael J. Jackson ; Tara Banerji ; Jorgen Scheel-Krüger ; Peter Jenner	The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets.
000991 (2003)	Peter Teismann [États-Unis] ; Kim Tieu ; Oren Cohen ; Dong-Kug Choi ; Du Chu Wu ; Daniel Marks ; Miquel Vila ; Vernice Jackson-Lewis ; Serge Przedborski	Pathogenic role of glial cells in Parkinson's disease.
000A92 (2003)	Michael Orth [Royaume-Uni] ; Sarah J. Tabrizi	Models of Parkinson's disease.
000B35 (1992)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P J Bédard	Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
000B37 (1992)	M R Luquin ; O. Scipioni ; J. Vaamonde ; O. Gershanik ; J A Obeso	Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
000B38 (1992)	S A Factor [États-Unis] ; D. Brown	Clozapine prevents recurrence of psychosis in Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Dopamine Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Dopamine Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dopamine Agents
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024